MedTrace Logo

A Pilot Clinical Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

NCT06780852 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-03-11

No results posted yet for this study

Summary

This clinical pilot study will evaluate the use of a bioresorbable bone adhesive to improve cranial flap fixation at two study time points (at the time of fixation and 6 months). The aim of this Pilot Study is to demonstrate the safety and efficacy of the use of Tetranite for Cranial Flap Fixation (TN-CFF) to allow clinical study of the TN-CFF device in a greater number of patients.

Conditions

  • Craniotomy

Interventions

DEVICE

Tetranite for Cranial Flap Fixation (TN-CFF)

Bioresorbable bone adhesive for cranial flap fixation following a craniotomy.

Sponsors & Collaborators

  • RevBio

    lead INDUSTRY

Principal Investigators

  • Kumar Abhinav, BSc MBBS MD FRCS(Neurosurgery) · Bristol Southmead Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2026-06-15
Completion
2027-01-15
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06780852 on ClinicalTrials.gov